Literature DB >> 24597471

Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps.

P-P Cao1, Y-N Zhang, B Liao, J Ma, B-F Wang, H Wang, M Zeng, W-H Liu, R P Schleimer, Z Liu.   

Abstract

BACKGROUND: Eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps (CRSwNP) display distinct patterns of inflammation. However, the pathogenic mechanisms underlying the heterogeneity of CRSwNP need further investigation.
OBJECTIVE: To investigate local immunoglobulin E (IgE) production and phenotype of mast cells in eosinophilic and non-eosinophilic CRSwNP in Chinese.
METHODS: Total and specific IgE levels were analysed by means of the ImmunoCAP system. The molecular steps involved in class-switch recombination to IgE were investigated using RT-PCR assays. Mast cell phenotypes, IgE- and high-affinity IgE receptor (FcεRI)-positive cells, and allergen binding to specific IgE in sinonasal mucosa were determined by means of immunohistochemistry.
RESULTS: Compared with controls and non-eosinophilic CRSwNP, local total IgE levels were increased, and local specific IgE to common aeroallergens was more frequently found, in Chinese eosinophilic CRSwNP independent of atopy and without significant association with Staphylococcus aureus enterotoxins. The ε germline gene transcript was also more frequently detected in eosinophilic CRSwNP. The number of IgE- and FcεRI-positive cells was increased in eosinophilic CRSwNP. Most IgE- and FcεRI-positive cells were mast cells. Dust mite antigens could bind to IgE on mast cells in situ. The number of mast cells positive for both tryptase and chymase and activated mast cells was increased in eosinophilic CRSwNP and the number of activated mast cells positively correlated with local IgE level, eotaxin-1 level, and eosinophil count in CRSwNP. CONCLUSIONS AND CLINICAL RELEVANCE: The local IgE induced by common aeroallergens may mediate mast cell activation and contribute to subsequent eosinophilic inflammation in Chinese CRSwNP. This study offers a rationale for considering intervention strategies designed to target 'local allergy' in eosinophilic CRSwNP.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic rhinosinusitis; eosinophil; immunoglobulin E; mast cell; nasal polyps

Mesh:

Substances:

Year:  2014        PMID: 24597471      PMCID: PMC4013492          DOI: 10.1111/cea.12304

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  27 in total

1.  Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis.

Authors:  Pooja Takhar; Lyn Smurthwaite; Heather A Coker; David J Fear; Graham K Banfield; Victoria A Carr; Stephen R Durham; Hannah J Gould
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 2.  Local isotype switching to IgE in airway mucosa.

Authors:  Pierre Olivier Fiset; Lisa Cameron; Qutayba Hamid
Journal:  J Allergy Clin Immunol       Date:  2005-07       Impact factor: 10.793

3.  Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China.

Authors:  Nan Zhang; Gabriele Holtappels; Cindy Claeys; Ganquan Huang; Paul van Cauwenberge; Claus Bachert
Journal:  Am J Rhinol       Date:  2006 Jul-Aug

Review 4.  Immunological memory.

Authors:  D Gray
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.

Authors:  C Bachert; P Gevaert; G Holtappels; S G Johansson; P van Cauwenberge
Journal:  J Allergy Clin Immunol       Date:  2001-04       Impact factor: 10.793

6.  Group II subfamily secretory phospholipase A2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps.

Authors:  Z Liu; X Lu; H Wang; X J You; Q X Gao; Y H Cui
Journal:  Allergy       Date:  2007-06-18       Impact factor: 13.146

Review 7.  Rhinosinusitis: establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

Review 8.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

Authors:  J Bousquet; R Lockey; H J Malling
Journal:  J Allergy Clin Immunol       Date:  1998-10       Impact factor: 10.793

9.  Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma.

Authors:  Pooja Takhar; Christopher J Corrigan; Lyn Smurthwaite; Brian J O'Connor; Stephen R Durham; Tak H Lee; Hannah J Gould
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

10.  Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps.

Authors:  P Gevaert; K T Nouri-Aria; H Wu; C E Harper; P Takhar; D J Fear; F Acke; N De Ruyck; G Banfield; H H Kariyawasam; C Bachert; S R Durham; H J Gould
Journal:  Allergy       Date:  2012-11-15       Impact factor: 13.146

View more
  33 in total

Review 1.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

2.  Long-term effects of adenotonsillectomy on serum-specific immunoglobulin E.

Authors:  Lijuan Song; Jinfei Guo; Wenjing Liao; Peichang Ye; Li Liu; Tao Chen; Pingchang Yang; Nanshan Zhong; Baoqing Sun; Xiaowen Zhang
Journal:  Pediatr Res       Date:  2017-08-02       Impact factor: 3.756

Review 3.  Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis.

Authors:  Anna G Staudacher; Anju T Peters; Atsushi Kato; Whitney W Stevens
Journal:  Ann Allergy Asthma Immunol       Date:  2020-01-30       Impact factor: 6.347

Review 4.  The role of local allergy in the nasal inflammation.

Authors:  Ke-Jia Cheng; Min-Li Zhou; Ying-Ying Xu; Shui-Hong Zhou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-17       Impact factor: 2.503

Review 5.  Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function.

Authors:  Joseph M Kulinski; Rosa Muñoz-Cano; Ana Olivera
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

Review 6.  Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes.

Authors:  Ping-Ping Cao; Zhi-Chao Wang; Robert P Schleimer; Zheng Liu
Journal:  Ann Allergy Asthma Immunol       Date:  2018-10-13       Impact factor: 6.347

7.  Functional role of kynurenine and aryl hydrocarbon receptor axis in chronic rhinosinusitis with nasal polyps.

Authors:  Heng Wang; Danh C Do; Jinxin Liu; Baofeng Wang; Jingjing Qu; Xia Ke; Xiaoyan Luo; Ho Man Tang; Ho Lam Tang; Chengping Hu; Mark E Anderson; Zheng Liu; Peisong Gao
Journal:  J Allergy Clin Immunol       Date:  2017-07-06       Impact factor: 10.793

8.  Different roles of Staphylococcus aureus enterotoxin in different subtypes of nasal polyps.

Authors:  Ke-Jia Cheng; Shen-Qing Wang; Ying-Ying Xu
Journal:  Exp Ther Med       Date:  2016-12-02       Impact factor: 2.447

9.  Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes.

Authors:  B Liao; J-X Liu; Z-Y Li; Z Zhen; P-P Cao; Y Yao; X-B Long; H Wang; Y Wang; R Schleimer; Z Liu
Journal:  Allergy       Date:  2018-01-26       Impact factor: 13.146

Review 10.  Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.

Authors:  Tetsuji Takabayashi; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2020-03       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.